Control of metastatic progression by microRNA regulatory networks

Nature Cell Biology

Volumn 15, Issue 6, 2013, Pages 546-554

  Pencheva, Nora ^a   Tavazoie, Sohail F ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ARGONAUTE PROTEIN; DNA DIRECTED RNA POLYMERASE III; HERMES ANTIGEN; LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 141; MICRORNA 145; MICRORNA 15A; MICRORNA 16; MICRORNA 200; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 21; MICRORNA 30B; MICRORNA 30D; MICRORNA 31; MICRORNA 373; MICRORNA 429; MICRORNA 520C; RNA BINDING PROTEIN; RNA BINDING PROTEIN DGCR8; RNA BINDING PROTEIN TARBP2; RNA INDUCED SILENCING COMPLEX; RNA POLYMERASE II; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BACH1; UNCLASSIFIED DRUG; UVOMORULIN;

BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CD44 GENE; CELL MIGRATION; COLORECTAL CANCER; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; GENE REPRESSION; HUMAN; MELANOMA; METASTASIS; MIR 335 GENE; PRIORITY JOURNAL; REGULATORY RNA SEQUENCE; REVIEW; RNA PROCESSING; RNA TRANSCRIPTION; RNA TRANSLATION; SOX4 GENE; TENASCIN C GENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; REGULATORY SEQUENCES, RIBONUCLEIC ACID; SIGNAL TRANSDUCTION;

EID: 84878595514     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2769     Document Type: Review

References (136)

1. Talmadge, J.E. Fidler, I.J. AACR Centennial Series: The biology of cancer metastasis: historical perspective. Cancer Res. 70, 5649-5669 (2010).
2. Gupta, G.P. Massagué, J. Cancer metastasis: building a framework. Cell 127, 679-695 (2006).
3. Hanahan, D. Weinberg, R.A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
4. Minn, A.J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524 (2005).
5. Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549 (2003).
6. Tavazoie, S.F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152 (2008).
7. Wang, Y. et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679 (2005).
8. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
9. He, L. Hannon, G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531 (2004).
10. Lujambio, A. Lowe, S.W. The microcosmos of cancer. Nature 482, 347-355 (2012).
11. Bushati, N. Cohen, S.M. MicroRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175-205 (2007).
12. Ebert, M.S. Sharp, P.A. Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515-524 (2012).
13. Filipowicz, W., Bhattacharyya, S.N. Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114 (2008).
14. Ul Hussain, M. Micro-RNAs (miRNAs): genomic organisation, biogenesis and mode of action. Cell Tissue Res. 349, 405-413 (2012).
15. Kim, V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6, 376-385 (2005).
16. Winter, J., Jung, S., Keller, S., Gregory, R.I. Diederichs, S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11, 228-234 (2009).
17. Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419 (2003).
18. Bernstein, E., Caudy, A.A., Hammond, S.M. Hannon, G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366 (2001).
19. Gregory, R.I., Chendrimada, T.P., Cooch, N. Shiekhattar, R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123, 631-640 (2005).
20. Liu, J. et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437-1441 (2004).
21. Meister, G. et al. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15, 185-197 (2004).
22. Czech, B. Hannon, G.J. Small RNA sorting: matchmaking for Argonautes. Nat. Rev. Genet. 12, 19-31 (2011).
23. Ding, L. Han, M. GW182 family proteins are crucial for microRNA-mediated gene silencing. Trends Cell Biol. 17, 411-416 (2007).
24. Duursma, A.M., Kedde, M., Schrier, M., le Sage, C. Agami, R. miR 2011;148 targets human DNMT3b protein coding region. RNA 14, 872-877 (2008).
25. Forman, J.J., Legesse-Miller, A. Coller, H.A. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc. Natl Acad. Sci. USA 105, 14879-14884 (2008).
26. Forman, J.J. Coller, H.A. The code within the code: microRNAs target coding regions. Cell Cycle 9, 1533-1541 (2010).
27. Chi, S.W., Zang, J.B., Mele, A. Darnell, R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460, 479-486 (2009).
28. Hafner, M. et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129-141 (2010).
29. Calin, G.A. Croce, C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866 (2006).
30. Garzon, R., Calin, G.A. Croce, C.M. MicroRNAs in Cancer. Annu. Rev. Med. 60, 167-179 (2009).
31. Calin, G.A. et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99, 15524-15529 (2002).
32. Michael, M.Z., O' Connor, S.M., van Holst Pellekaan, N.G., Young, G.P. James, R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1, 882-891 (2003).
33. Iorio, M.V. et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065-7070 (2005).
34. Takamizawa, J. et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753-3756 (2004).
35. Yanaihara, N. et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198 (2006).
36. Farazi, T.A. et al. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 71, 4443-4453 (2011).
37. Hayashita, Y. et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65, 9628-9632 (2005).
38. He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828-833 (2005).
39. Eis, P.S. et al. Accumulation of miR-155 and BIC RNA in human Bcell lymphomas. Proc. Natl Acad. Sci. USA 102, 3627-3632 (2005).
40. Kluiver, J. et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large Bcell lymphomas. J.Pathol. 207, 243-249 (2005).
41. Medina, P.P., Nolde, M. Slack, F.J. OncomiR addiction in an invivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90 (2010).
42. Tagawa, H. Seto, M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 19, 2013-2016 (2005).
43. Mu, P. et al. Genetic dissection of the miR 2011;17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23, 2806-2811 (2009).
44. Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 103, 2257-2261 (2006).
45. Calin, G.A. et al. MicroRNA profiling reveals distinct signatures in Bcell chronic lymphocytic leukemias. Proc. Natl Acad. Sci. USA 101, 11755-11760 (2004).
46. Ciafrè, S.A. et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334, 1351-1358 (2005).
47. Murakami, Y. et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25, 2537-2545 (2006).
48. Yanaihara, N. et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198 (2006).
49. Roldo, C. et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J.Clin. Oncol. 24, 4677-4684 (2006).
50. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005).
51. Ozen, M., Creighton, C.J., Ozdemir, M. Ittmann, M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27, 1788-1793 (2008).
52. Thomson, J.M. et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20, 2202-2207 (2006).
53. Kumar, M.S., Lu, J., Mercer, K.L., Golub, T.R. Jacks, T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39, 673-677 (2007).
54. Yan, M. et al. Dysregulated expression of dicer and drosha in breast cancer. Pathol. Oncol. Res. 18, 343-348 (2012).
55. He, L. et al. A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134 (2007).
56. Chang, T.C. et al. Transactivation of miR 2011;34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26, 745-752 (2007).
57. Hollstein, M., Sidransky, D., Vogelstein, B. Harris, C.C. p53 mutations in human cancers. Science 253, 49-53 (1991).
58. Ventura, A. et al. Restoration of p53 function leads to tumour regression invivo. Nature 445, 661-665 (2007).
59. Png, K.J. et al. MicroRNA 2011;335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev. 25, 226-231 (2011).
60. Wang, F., Zheng, Z., Guo, J. Ding, X. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol. Oncol. 119, 586-593 (2010).
61. Hafez, M.M. et al. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Asian Pac. J.Cancer Prev. 13, 591-598 (2012).
62. Schmitz, K.J. et al. Differential expression of microRNA 2011;675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours. J.Clin. Pathol. 64, 529-535 (2011).
63. Dohi, O. et al. Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma. Int. J.Oncol. 42, 411-418 (2013).
64. White, N.M. et al. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J.Urol. 186, 1077-1083 (2011).
65. Missiaglia, E. et al. MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br. J.Cancer 102, 1769-1777 (2010).
66. Donnem, T. et al. Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer 117, 3193-3200 (2011).
67. Xu, Y. et al. MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 31, 1398-1407 (2012).
68. Heyn, H. et al. MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development. Int. J.Cancer 129, 2797-2806 (2011).
69. Taulli, R. et al. The muscle-specific microRNA miR 2011;206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J.Clin. Invest. 119, 2366-2378 (2009).
70. Hamada, S. et al. MiR 2011;126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res 10, 3-10 (2012).
71. Feng, R. et al. miR 2011;126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298, 50-63 (2010).
72. Liu, B., Peng, X.C., Zheng, X.L., Wang, J. Qin, Y.W. MiR 2011;126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines invitro and invivo. Lung Cancer 66, 169-175 (2009).
73. Png, K.J., Halberg, N., Yoshida, M. Tavazoie, S.F. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481, 190-194 (2012).
74. Oskarsson, T. et al. Breast cancer cells produce tenascinC as a metastatic niche component to colonize the lungs. Nat. Med. 17, 867-874 (2011).
75. O'Connell, J.T. et al. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc. Natl Acad. Sci. USA 108, 16002-16007 (2011).
76. Zhang, J. et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res 72, 4597-4608 (2012).
77. Valastyan, S. et al. A pleiotropically acting microRNA, miR 2011;31, inhibits breast cancer metastasis. Cell 137, 1032-1046 (2009).
78. Valastyan, S., Benaich, N., Chang, A., Reinhardt, F. Weinberg, R.A. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes Dev. 23, 2592-2597 (2009).
79. Valastyan, S., Chang, A., Benaich, N., Reinhardt, F. Weinberg, R.A. Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res. 70, 5147-5154 (2010).
80. Wszolek, M.F. et al. A microRNA expression profile defining the invasive bladder tumor phenotype. Urol. Oncol. 29, 794-801 (2011).
81. Schaefer, A. et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J.Cancer 126, 1166-1176 (2010).
82. Creighton, C.J. et al. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res. 70, 1906-1915 (2010).
83. Zhang, Y. et al. Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med. Oncol. 27, 685-689 (2010).
84. Ma, L., Teruya-Feldstein, J. Weinberg, R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688 (2007).
85. Hakem, A. et al. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev. 19, 1974-1979 (2005).
86. Ma, L. et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat. Biotechnol. 28, 341-347 (2010).
87. Huang, Q. et al. The microRNAs miR 2011;373and miR 2011;520c promote tumour invasion and metastasis. Nat. Cell Biol. 10, 202-210 (2008).
88. Gregory, P.A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601 (2008).
89. Korpal, M., Lee, E.S., Hu, G. Kang, Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J.Biol. Chem. 283, 14910-14914 (2008).
90. Park, S.M., Gaur, A.B., Lengyel, E. Peter, M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907 (2008).
91. Burk, U. et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582-589 (2008).
92. Gibbons, D.L. et al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev. 23, 2140-2151 (2009).
93. Korpal, M. et al. Direct targeting of Sec23a by miR 2011;200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med. 17, 1101-1108 (2011).
94. Ma, L. et al. miR 2011;9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 12, 247-256 (2010).
95. Chen, D. et al. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat. Med. 18, 1511-1517 (2012).
96. Zhu, S., Si, M.L., Wu, H. Mo, Y.Y. MicroRNA 2011;21 targets the tumour suppressor gene tropomyosin1 (TPM1). J.Biol. Chem. 282, 14328-14336 (2007).
97. Zhu, S. et al. MicroRNA 2011;21 targets tumour suppressor genes in invasion and metastasis. Cell Res. 18, 350-359 (2008).
98. Asangani, I.A. et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136 (2008).
99. Bornachea, O. et al. EMT and induction of miR 2011;21 mediate metastasis development in Trp53-deficient tumours. Sci. Rep. 2, 434 (2012).
100. Segura, M.F. et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc. Natl Acad. Sci. USA 106, 1814-1819 (2009).
101. Gaziel-Sovran, A. et al. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 20, 104-118 (2011).
102. Pencheva, N. et al. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151, 1068-1082 (2012).
103. Yu, F. et al. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (2007).
104. Dangi-Garimella, S. et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 28, 347-358 (2009).
105. Yun, J. et al. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J. 30, 4500-4514 (2011).
106. Garner, K. et al. Phosphatidylinositol transfer protein, cytoplasmic1 (PITPNC1) binds and transfers phosphatidic acid. J.Biol. Chem. 287, 32263-32276 (2012).
107. Zhang, Y. et al. miR-126 and miR 2011;126(&z.ast;) repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat. Cell Biol. 15, 284-294 (2013).
108. Zhu, N. et al. Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. Mol. Cell Biochem. 351, 157-164 (2011).
109. Sasahira, T. et al. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br. J.Cancer 107, 700-706 (2012).
110. Chou, J. et al. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat. Cell Biol. 15, 201-213 (2012).
111. Ru, P. et al. miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Mol. Cancer Ther. 11, 1166-1173 (2012).
112. Fang, J.H. et al. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase2 expression. Hepatology 54, 1729-1740 (2011).
113. Zhuang, G. et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 31, 3513-3523 (2012).
114. Wolfers, J. et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7, 297-303 (2001).
115. Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891 (2012).
116. Bracken, C.P. et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 68, 7846-7854 (2008).
117. Siemens, H. et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 10, 4256-4271 (2011).
118. Grelier, G. et al. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br. J.Cancer 101, 673-683 (2009).
119. Martello, G. et al. A microRNA targeting dicer for metastasis control. Cell 141, 1195-1207 (2010).
120. Su, X. et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467, 986-990 (2010).
121. Melo, S.A. et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18, 303-315 (2010).
122. Kota, J. et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017 (2009).
123. Miyazaki, Y. et al. Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nat. Med. 18, 1136-1141 (2012).
124. Obad, S. et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat. Genet. 43, 371-378 (2011).
125. Elmén, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008).
126. Lanford, R.E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitisC virus infection. Science 327, 198-201 (2010).
127. Gregory, P.A. et al. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol. Biol. Cell 22, 1686-1698 (2011).
128. Liu, C. et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 17, 211-215 (2011).
129. Yang, S. et al. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene (2012).
130. Wong, C.C. et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase2. Gastroenterology 140, 322-331 (2011).
131. Penna, E. et al. MicroRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J. 30, 1990-2007 (2011).
132. Li, X. et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol. Cancer Res. 9, 824-833 (2011).
133. Zhang, X., Liu, S., Hu, T., He, Y. Sun, S. Up-regulated microRNA-143 transcribed by nuclear factorB enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50, 490-499 (2009).
134. Zou, Z. et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263, 526-529 (1994).
135. Dorrello, N.V. et al. S6K1-and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314, 467-471 (2006).
136. Latha, K., Zhang, W., Cella, N., Shi, H.Y. Zhang, M. Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol. Cell Biol. 25, 1737-1748 (2005).